Gastrointestinal Cancers
Getting treated for gastrointestinal cancers at City of Hope puts your care in the hands of world experts in cancers affecting the digestive system. It means comprehensive, multidisciplinary care from a team offering the newest, leading-edge treatments for early- and late-stage GI cancer, including robotic and minimally invasive surgery and precision medicine.
City of Hope’s approach to treating gastrointestinal cancers starts with a coordinated, multidisciplinary care team whose primary goals are helping you live a long, healthy life free from cancer.
Clinical trials — research studies that involve volunteer patients — are a crucial component to developing new, more effective gastrointestinal cancer treatments that save lives.
When you come to City of Hope, you have access to a strong network of support services and staff to help you and your family along your gastrointestinal cancer journey.
Our team works together to ensure you get the best gastrointestinal cancer treatments and the best survival outcomes using:
- Minimally invasive, robotically assisted surgical techniques to remove tumors with less discomfort, reduced risk of complications and shorter recovery times.
- Highly precise radiation therapy to treat tumors with minimal exposure to surrounding normal tissue.
- Targeted drugs and drug combinations that treat advanced GI cancers with greater effectiveness and fewer side effects than traditional chemotherapy.
- A wide range of GI cancer clinical trials, giving patients access to the newest cancer treatments and tests not readily available elsewhere.
- Supportive care services to help patients and their loved ones with wellness and palliative care issues that may arise during and after GI cancer treatment.

City of Hope is one of the few facilities designated a comprehensive cancer center by the National Cancer Institute.

Our developments in the areas of breakthrough cancer drugs, bone marrow transplants and CAR T cell therapy are recognized internationally.

Our leadership in research and innovation continually enhances our ability to provide novel and differentiated approaches to cancer care.

Afsaneh Barzi, M.D., Ph.D., is a medical oncologist at City of Hope.
Yi-Jen Chen, M.D., Ph.D., is a radiation oncologist specializing in gastrointestinal cancers, gynecological cancers and esophageal cancers.
Vincent Chung, M.D., is a medical oncologist specializing in pancreatic cancer and gastrointestinal cancers.
Marwan G. Fakih, M.D., is a medical oncologist specializing in gastrointestinal cancers at City of Hope's Duarte and Newport Beach locations.

Gregory Idos, M.D., M.S., is a gastroenterologist at City of Hope.
Jonathan Kessler, M.D., is a interventional radiologist specializing in colon, liver, kidney cancers.
Trilokesh Kidambi, M.D., a gastroenterologist with a specialty colorectal cancer screening at City of Hope, near Los Angeles.
Daneng Li, M.D., is a medical oncologist specializing in geriatric oncology and treating gastrointestinal cancers.

Moshe Faynsod, M.D., is surgical oncologist at City of Hope ǀ South Bay in Torrance, California.
Dean W. Lim, M.D., is a medical oncologist and professor in the Department of Medical Oncology & Therapeutics.
James Lin, M.D., is highly experienced in the field of endoscopic ultrasound, ERCP and other advanced endoscopy services.
Laleh G. Melstrom, M.D., M.S., specializes in melanoma and pancreatic cancers.
I. Benjamin Paz, M.D., is a nationally renowned surgical oncology surgeon, with expertise in breast cancer, gastrointestinal and rectal cancers, and tumors involving the bone and soft tissues.

Mustafa Raoof, M.D., M.S., is a surgical oncologist and an assistant professor in the Department of Surgery and in the Department of Cancer Genetics and Epigenetics.
Stephen M. Sentovich, M.D., M.B.A., is a colorectal surgeon and a clinical professor in the Division of Colorectal Surgery, Department of Surgery.

Dupinder Singh, M.D., is a gastroenterologist-hepatologist in the Department of Medicine at City of Hope.
Vijay Trisal, M.D., the Dr. Norman & Melinda Payson Professor in Medicine and chief medical officer at City of Hope, is an advocate for individualized patient care and expanding access to City of Hope’s advanced therapies and specialized physicians across local communities.
Yanghee Woo, M.D., is director of the Gastroenterology Minimally Invasive Therapy Program.